Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Dr Reddy's Labs Q3 Results: Dr Reddy's Laboratories on Thursday reported a 2% year-on-year growth in its December quarter consolidated net profit at Rs 1,413 crore versus Rs 1,379 crore posted in the ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Dr. Reddy's Lab is undervalued due to exaggerated concerns about Revlimid revenue decline and the underappreciated potential of new high-growth products like biosimilars and GLP-1 drugs.

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

Bank of India Multi Asset Allocation Fund-Reg (G) 2.81 21,000 0.83 Bank of India Multi Asset Allocation Fund-Reg (IDCW) 2.81 21,000 0.83 Bank of India Multi Asset ...

Dr. Reddy's Laboratories, Adani Energy Solutions Ltd. and Mankind Pharma Ltd. are among the top names that will announce their earnings for the third quarter on Thursday. (Photo source: Dr Reddy's ...

Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 1,03,189.04 Crore) operating in Pharmaceuticals sector. Dr. Reddy's Laboratories Ltd. key ...

For the first time in almost 20 years, Walmart has a new logo. The international retailer describes it as a “a comprehensive brand refresh,” but the online world hasn’t been quite so kind to ...